Table 3.
Overview on the Enterocytozoon bieneusi infection status and the medical history of treatments or an additional disease. All tests were calculated with a significance level of p < 0.05
E. bieneusi status | |||||
---|---|---|---|---|---|
Positive | Negative | Total | p value | ||
Antimicrobial treatment | Yes | 8 | 42 | 50 | 0.012 |
No | 6 | 121 | 127 | ||
Total | 14 | 163 | 177 | ||
Antiprotozoal treatment* | Yes | 2 | 21 | 23 | 0.881 |
No | 12 | 142 | 154 | ||
Total | 14 | 163 | 177 | ||
Antiphlogistic treatment | Yes | 2 | 29 | 31 | 0.741 |
No | 12 | 134 | 146 | ||
Total | 14 | 163 | 177 | ||
Additional diseases# | Yes | 2 | 22 | 24 | 0.934 |
No | 12 | 141 | 153 | ||
Total | 14 | 163 | 177 |
*Antiprotozoal treatment including halofuginone and toltrazuril/diclazuril; #besides diarrhea: omphalitis and/or pneumonia